Strides Pharma surges post inspection
Strides Pharma surges post inspection

Strides Pharma surges post inspection

Sanket Dewarkar Article rating: 5.0

The facility (KRS Gardens) in Bangalore is the largest facility for the company and has the capability in several dosage formats including tablets, capsules (both hard gelatin and soft gelatin), ointments, creams and liquids. The facility supports several important current and future submissions for the US market.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.21 crore contracts with a turnover of Rs. 7,00,968.41 crore.

Technofab Engg wins orders worth Rs. 389 crore
Technofab Engg wins orders worth Rs. 389 crore

Technofab Engg wins orders worth Rs. 389 crore

Pratik Shastri Article rating: 5.0

Technofab Engineering, an engineering procurement and construction services company, reported in a press release that it has won two new turnkey projects worth Rs. 389 crore in the electrical sector.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.21 crore contracts with a turnover of Rs. 7,00,968.41 crore. 

Index trend and stocks in action November 05, 2018
Index trend and stocks in action November 05, 2018

Index trend and stocks in action November 05, 2018

Karan Dsij Article rating: 4.0

Going ahead, the opening upside gap area (10,442-10,458), which was created on November 2, is likely to act as a support area for the index. Stocks in news: Strides Pharma Science, Dr Reddy’s Laboratories, Laurus Labs, KEC International and Linde India.

Market may begin on a cautious note tracking weak global cues
Market may begin on a cautious note tracking weak global cues

Market may begin on a cautious note tracking weak global cues

Karan Dsij Article rating: 5.0

The key Indian equity indices are likely to witness a cautious start due to weakness in equity markets across the world. A negative trend in the SGX Nifty index future, which was trading at 10,550, down by 38 points, also indicated negative opening.

IRDAI moots 5 changes to life insurance policies
IRDAI moots 5 changes to life insurance policies

IRDAI moots 5 changes to life insurance policies

Prakash Patil Article rating: 5.0

The Insurance Regulatory and Development Authority of India (IRDAI) on October 26, 2018, proposed significant changes in life insurance policies that will provide considerable benefits to the policyholders. 

The risks of being a loan guarantor
The risks of being a loan guarantor

The risks of being a loan guarantor

Prakash Patil Article rating: 5.0

If one of your relatives, friends or office colleagues asks you whether you could become a ‘guarantor’ for a home loan he is applying, you may obliged to reply in the affirmative.

Pros & cons of joint life term insurance plan
Pros & cons of joint life term insurance plan

Pros & cons of joint life term insurance plan

Prakash Patil Article rating: 5.0

The joint term insurance plan offers the facility of protecting you and your spouse with a single life insurance policy. The policy can be bought by working couples or by couples where one spouse is a homemaker.

RSS
First31543155315631573159316131623163Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR